Back

Assessing TAVI: vital clinical impact or therapeutic ineffectiveness?

12 May 2024 (16:00 - 17:00)
Organised by: Logo
Congress Presentation Part of: ePosters in interventional cardiology and pharmacology 1 Aortic Valve Intervention HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Mariana Rodrigues Simoes

Coimbra Hospital and University Center, Coimbra (Portugal)

7 More presentations in this session

Presentation thumbnail
Radiofrequency catheter ablation of anteroseptal and midseptal accessory pathways in the era of electroanatomic mapping systems and irrigated catheters
Ms C. Marques (Porto, PT)
Abstract Slides Video
Presentation thumbnail
The missing piece: transcatheter PFO closure in patients above 55
Doctor A. Silva (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Left ventricular transradial endomyocardial biopsy: a safe and effective approach
Doctor A. Abrantes (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Pacemaker implantation and dependency after TAVI - a tertiary center experience
Doctor J. Mesquita Guimaraes (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Prevalence, predictors and prognostic significance of acute kidney recovery following transcatheter aortic valve implantation
Doctor A. Pinho (Porto, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in interventional cardiology and pharmacology 1

The Event

Event poster

Heart Failure 2024

12 May 2024 16:00 CET
You may be interested in
thumbnail
Congress Presentation
Survival penalty in patients undergoing transcatheter versus surgical aortic valve replacement: is it just a question of frailty? Insights from a large cohort with demographic matching
thumbnail
Congress Presentation
Change in frailty in patients with aortic stenosis undergoing transcatheter or surgical aortic valve replacement, a systematic review and meta-analysis
thumbnail
Congress Presentation
Clinical impact of transcatheter aortic valve implantation (TAVI) in frail patients: a single-center prospective study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources